RSS Feeds
γ-Hydroxybutyrate Use in Older Adults
- D. Eric Brush, MD;
- Steven B. Bird, MD; and
- Edward W. Boyer, MD, PhD
- From University of Massachusetts Medical Center, Worcester, MA 01655.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Use of the “club drug” γ-hydroxybutyrate (GHB), or its precursors γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), is highly prevalent among youths seeking euphoric effects and body builders hoping to increase growth hormone production (1, 2). According …
